Document is current

Article History

Received: 8 January 2018

Accepted: 21 May 2018

First Online: 20 June 2018

Ethics approval and consent to participate

: The Hamilton Integrated Research Ethics Board granted the approval for this study protocol 2017-2812. Following ethics approval, we will start recruiting LTC sites by proactively approaching the LTC site manager and their clinicians (February to May 2017). We will hold scheduled information sessions at each LTC site to describe the intervention and project. The study coordinator will obtain written consent from willing participants (referring clinicians). Participants may also provide verbal and written consent when they call into GeriMedRisk to request a consultation. For participating sites, we will advertise the trial through posters displayed in common clinical staff areas and directly send a flyer to patients and their caregivers which describes the option and procedure to opt out of the intervention. We will track patients who opted out (personally or by caregiver proxy) of GeriMedRisk and inform their clinician of their decision.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.